• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Death Dis . Blood matters: the hematological signatures of Coronavirus infection

tetano

Editor, Senior Moderator
Cell Death Dis


. 2024 Nov 28;15(11):863.
doi: 10.1038/s41419-024-07247-8. Blood matters: the hematological signatures of Coronavirus infection

Ayelen Toro[SUP] #[/SUP][SUP] 1 2 [/SUP], Ana P Arévalo[SUP] #[/SUP][SUP] 3 [/SUP], Marianoel Pereira-Gómez[SUP] #[/SUP][SUP] 4 5 [/SUP], Agustina Sabater[SUP] 6 7 8 [/SUP], Eric A Zizzi[SUP] 9 10 [/SUP], Paula Perbolianachis[SUP] 4 5 [/SUP], Gaston Pascual[SUP] 6 7 [/SUP], Sofia Lage-Vickers[SUP] 6 7 [/SUP], Jorge L Pórfido[SUP] 3 [/SUP], Ines Achinelli[SUP] 6 7 [/SUP], Rocio Seniuk[SUP] 6 7 [/SUP], Juan Bizzotto[SUP] 6 7 8 [/SUP], Pablo Sanchis[SUP] 6 7 8 [/SUP], Alvaro Olivera[SUP] 11 [/SUP], Alejandro Leyva[SUP] 12 13 [/SUP], Pilar Moreno[SUP] 4 5 [/SUP], Alicia Costábile[SUP] 4 5 14 15 [/SUP], Alvaro Fajardo[SUP] 4 5 [/SUP], Federico Carrión[SUP] 16 [/SUP], Martín Fló[SUP] 16 17 [/SUP], Natalia Olivero-Deibe[SUP] 16 [/SUP], Fernando Rodriguez[SUP] 18 [/SUP], Nicolas Nin[SUP] 18 [/SUP], Nicolas Anselmino[SUP] 19 [/SUP], Estefania Labanca[SUP] 19 [/SUP], Elba Vazquez[SUP] 6 7 [/SUP], Javier Cotignola[SUP] 6 7 [/SUP], Daniel F Alonso[SUP] 20 [/SUP], Maria P Valacco[SUP] 6 7 [/SUP], Marcelo Marti[SUP] 6 7 [/SUP], Francesco Gentile[SUP] 10 21 [/SUP], Artem Cherkasov[SUP] 22 [/SUP], Martina Crispo[SUP] 23 [/SUP], Gonzalo Moratorio[SUP] 24 25 [/SUP], Geraldine Gueron[SUP] 26 27 [/SUP]



Affiliations
Abstract

Recent developments have broadened our perception of SARS-CoV-2, indicating its capability to affect the body systemically beyond its initial recognition as a mere respiratory pathogen. However, the pathways of its widespread are not well understood. Employing a dual-modality approach, we integrated findings from a Murine Hepatitis Virus (MHV) infection model with corroborative clinical data to investigate the pervasive reach of Coronaviruses. The novel presence of viral particles within red blood cells (RBCs) was demonstrated via high-resolution transmission electron microscopy, with computational modeling elucidating a potential heme-mediated viral entry mechanism via Spike protein affinity. Our data affirm viral localization in RBCs, suggesting heme moieties as facilitators for cellular invasion. Exacerbation of MHV pathology upon hemin administration, contrasted with chloroquine-mediated amelioration, underscoring a heme-centric pathway in disease progression. These observations extend the paradigm of Coronavirus pathogenicity to include hemoprotein interactions. This study casts new light on the systemic invasion capabilities of Coronaviruses, linking RBC hemoproteins with viral virulence. The modulation of disease severity through heme-interacting agents heralds a promising avenue for COVID-19 therapeutics. Our findings propose a paradigm shift in the treatment approach, leveraging the virus-heme interplay as a strategic hinge for intervention.


 
Back
Top Bottom